Results 241 to 250 of about 5,411,820 (260)

Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis

open access: yesMultiple Sclerosis Journal, 2013
Background: It is unclear if all patients with relapsing remitting multiple sclerosis (RRMS) ultimately develop progressive MS. Onset of progressive disease course seems to be age- rather than disease duration-dependent. Some forms of progressive MS (e.g.
Brian G Weinshenker, Moses Rodriguez
exaly   +2 more sources

Defining secondary progressive multiple sclerosis.

Brain, 2016
Raed Alroughani   +2 more
exaly  

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

New England Journal of Medicine, 2017
Fred D. Lublin   +2 more
exaly  

Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis

New England Journal of Medicine, 2018
Shlomo Shinnar   +2 more
exaly  

Demyelination versus remyelination in progressive multiple sclerosis.

Brain, 2010
Nils Koch-Henriksen   +2 more
exaly  

MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study

Multiple Sclerosis Journal, 2016
Sandra Vukusic   +2 more
exaly  

Diagnostic uncertainty during the transition to secondary progressive multiple sclerosis

Multiple Sclerosis Journal, 2014
Ilana Katz Sand   +2 more
exaly  

Progressive Multifocal Leukoencephalopathy Complicating Treatment with Natalizumab and Interferon Beta-1a for Multiple Sclerosis

New England Journal of Medicine, 2005
Bette K Kleinschmidt-Demasters   +1 more
exaly  

Home - About - Disclaimer - Privacy